,

Antibody Fc

Linking Adaptive and Innate Immunity

Specificaties
Gebonden, blz. | Engels
Elsevier Science | e druk, 2013
ISBN13: 9780123948021
Rubricering
Elsevier Science e druk, 2013 9780123948021
Verwachte levertijd ongeveer 9 werkdagen

Samenvatting

Antibody Fc is the first single text to synthesize the literature on the mechanisms underlying the dramatic variability of antibodies to influence the immune response. The book demonstrates the importance of the Fc domain, including protective mechanisms, effector cell types, genetic data, and variability in Fc domain function. This volume is a critical single-source reference for researchers in vaccine discovery, immunologists, microbiologists, oncologists and protein engineers as well as graduate students in immunology and vaccinology.

Antibodies represent the correlate of protection for numerous vaccines and are the most rapidly growing class of drugs, with applications ranging from cancer and infectious disease to autoimmunity. Researchers have long understood the variable domain of antibodies, which are responsible for antigen recognition, and can provide protection by blocking the function of their target antigen. However, recent developments in our understanding of the protection mediated by antibodies have highlighted the critical nature of the antibody constant, or Fc domain, in the biological activity of antibodies. The Fc domain allows antibodies to link the adaptive and innate immune systems, providing specificity to a wide range of innate effector cells. In addition, they provide a feedback loop to regulate the character of the immune response via interactions with B cells and antigen-presenting cells.

Specificaties

ISBN13:9780123948021
Taal:Engels
Bindwijze:Gebonden

Inhoudsopgave

<p>Part 1: Effector Mechanisms<br>Ch 1: Antibody Dependent Cellular Cytotoxicity<br>Ch 2: Antibody-Dependent Cellular Phagocytosis and its Impact on Pathogen Control<br>Ch 3: Interactions between the Complement System and Fcγ Receptors</p> <p>Part 2: Effector Cells<br>Ch 4: Natural Killer Cells<br>Ch 5: Phagocytes and Immunoglobulins<br>Ch 6: B Cells</p> <p>Part 3: FcR<br>Ch 7: Structural Recognition of Immunoglobulins by Fcg Receptors<br>Ch 8: FcγRs Across Species<br>Part 4: Variability of the Fc Domain<br>Ch 9: Human IgG Subclasses<br>Ch 10: Antibody Glycosylation</p> <p>Part 5: Genetic Associations<br>Ch 11: Activating and Inhibitory FcγRs in Autoimmune Disorders<br>Ch 12: Fcg Receptor Polymorphisms and Susceptibility to Infection<br>Ch 13: Role of IgG Fc Receptors in Monoclonal Antibody Therapy of Cancer</p> <p>Part 6: Evolving areas<br>Ch 14: Interactions Among Monoclonal Antibody Mechanisms of Action<br>Ch 15: Fc Receptor-Dependent Immunity<br>Ch 16: Fcγ Receptors as Therapeutic Targets<br>Ch 17: Fc Protein Engineering<br>Ch 18: Bacterial Modulation of Fc Effector Functions<br>Ch 19: Pathogenic Exploitation of Fc Activity<br>Ch 20: Mechanisms of Immunoglobulin-Mediated Mucus Entrapment of Pathogens at Various Mucosal Surfaces</p>

Rubrieken

    Personen

      Trefwoorden

        Antibody Fc